Jinoos Yazdany, MD, MPH

Professor

Dr. Yazdany is Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital (ZSFG) and the Alice Betts Endowed Professor of Medicine at UCSF. She received her undergraduate degree from Stanford, her MD from UCLA, and her MPH from Harvard. She joined the faculty after completing internal medicine residency and fellowship in rheumatology at UCSF. As a rheumatologist specializing in systemic lupus, she practices at ZSFG and co-directs the UCSF Health Lupus Clinic.

Dr. Yazdany’s scholarship focuses on improving health care quality, safety and outcomes for individuals with chronic rheumatic diseases. She co-directs the UCSF Rheumatology Quality and Informatics Lab, an interdisciplinary group that uses health services research, informatics, and implementation science to inform national health care improvement initiatives. She has worked with colleagues to develop the American College of Rheumatology’s RISE registry that aggregates and analyzes data from rheumatology practices around the country to inform quality improvement and research projects. She has developed a number of quality measures that have been endorsed by the National Quality Forum and are being used in federal programs. She has served as PI of grants from the NIH/NIAMS, AHRQ, and CDC and is the recipient of a NIAMS K24 mentoring award. Dr. Yazdany also serves as co-director of a research core – one focused on human subjects recruitment and clinical informatics support – for the NIH/NIAMS-funded P30 UCSF PREMIER Center.

Nationally, Dr. Yazdany has held numerous leadership positions, including serving as co-chair of the ACR’s Quality Measures Subcommittee, chair of the ACR’s Registries and Health IT Committee, chair of Research and Publications for the RISE registry, and member of the NQF’s Health Professional Council. She has earned several honors and awards for her work, including the Mary Betty Stevens Young Investigator Prize from the Lupus Foundation of America, the Ephraim Engleman Award for Arthritis Research, and the Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation.
Education
M.D., 2000 - School of Medicine, University of California Los Angeles
Residency, - Internal Medicine, University of California, San Francisco
Websites
Publications
  1. Lanata CM, Nititham J, Taylor KE, Solomon O, Chung SA, Blazer A, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, Barcellos LF, Criswell LA. The dynamics of methylation of CpG sites associated with SLE subtypes in a longitudinal cohort. 2022. PMID: 35635730


  2. Taylor T, Anastasiou C, Ja C, Rush S, Trupin L, Dall'Era M, Katz P, Barbour KE, Greenlund KJ, Yazdany J, Gianfrancesco MA. Causes of death among individuals with systemic lupus erythematosus by race and ethnicity: a population-based study. 2022. PMID: 35904969


  3. Izadi Z, Gianfrancesco MA, Aguirre A, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Seet AM, Schmajuk G, Jacobsohn L, Katz P, Rush S, Al-Emadi S, Sparks JA, Hsu TY, Patel NJ, Wise L, Gilbert E, Duarte-García A, Valenzuela-Almada MO, Ugarte-Gil MF, Ribeiro SLE, de Oliveira Marinho A, de Azevedo Valadares LD, Giuseppe DD, Hasseli R, Richter JG, Pfeil A, Schmeiser T, Isnardi CA, Reyes Torres AA, Alle G, Saurit V, Zanetti A, Carrara G, Labreuche J, Barnetche T, Herasse M, Plassart S, Santos MJ, Rodrigues AM, Robinson PC, Machado PM, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Yazdany J, Global Rheumatology Alliance Registry. Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry. 2022. PMID: 35869686


  4. Arora S, Katz P, Nika A, Sequeira W, Block JA, Yazdany J, Yelin E, Jolly M. Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life? 2022. PMID: 35792677


  5. Strait A, Graf J, Margaretten M, Yazdany J, Goglin S. Race, Ethnicity and Disparities in Rheumatology Educational Materials. 2021. PMID: 33768717


  6. Robinson PC, Yazdany J. Racial and ethnic differences in COVID-19 outcomes: a call to action. 2022. PMID: 35698724


  7. Patterson SL, Trupin L, Yazdany J, Dall'Era M, Lanata C, Dequattro K, Hartogensis W, Katz P. Physical Inactivity Independently Predicts Incident Depression in a Multi-Racial/Ethnic Systemic Lupus Cohort. 2021. PMID: 33421358


  8. Aguirre A, Izadi Z, Trupin L, Barbour KE, Greenlund KJ, Katz P, Lanata C, Criswell L, Dall'Era M, Yazdany J. Race, ethnicity, and disparities in risk of end-organ lupus manifestations following SLE diagnosis in a multiethnic cohort. 2022. PMID: 35452566


  9. DeQuattro K, Trupin L, Murphy LB, Rush S, Criswell LA, Lanata CM, Dall'Era M, Katz P, Yazdany J. High Disease Severity Among Asians in a US Multiethnic Cohort of Individuals with Systemic Lupus Erythematosus. 2020. PMID: 33337580


  10. Najjar R, Alexander SA, Hughes GC, Yazdany J, Singh N. Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the US: A Nationwide Study. 2022. PMID: 35439363


  11. Perez RK, Gordon MG, Subramaniam M, Kim MC, Hartoularos GC, Targ S, Sun Y, Ogorodnikov A, Bueno R, Lu A, Thompson M, Rappoport N, Dahl A, Lanata CM, Matloubian M, Maliskova L, Kwek SS, Li T, Slyper M, Waldman J, Dionne D, Rozenblatt-Rosen O, Fong L, Dall'Era M, Balliu B, Regev A, Yazdany J, Criswell LA, Zaitlen N, Ye CJ. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. 2022. PMID: 35389781


  12. Liew J, Gianfrancesco M, Harrison C, Izadi Z, Rush S, Lawson-Tovey S, Jacobsohn L, Ja C, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Schäfer M, Frãzao-Mateus E, Bulina I, Stafford F, Tufan A, Graver C, Yardimci GK, Zepa J, Al Emadi S, Cook C, Abutiban F, Dey D, Katigbak G, Kaufman L, Kowalski E, Martínez-Martínez MU, Patel NJ, Reyes-Cordero G, Salido E, Smith E, Snow D, Sparks J, Wise L, Bhana S, Gore-Massy M, Grainger R, Hausmann J, Sirotich E, Sufka P, Wallace Z, Machado PM, Robinson PC, Yazdany J. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry. 2022. PMID: 35387864


  13. Bruera S, Lei X, Blau B, Zhao H, Deswal A, Yazdany J, Giordano SH, Suarez-Almazor ME. Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus. 2022. PMID: 35294107


  14. Grainger R, Kim AHJ, Conway R, Yazdany J, Robinson PC. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. 2022. PMID: 35217850


  15. Young K, Yeoh SA, Putman M, Sattui S, Conway R, Graef E, Kilian A, Konig M, Sparks J, Ugarte-Gil M, Upton L, Berenbaum F, Bhana S, Costello W, Hausmann J, Machado P, Robinson P, Sirotich E, Sufka P, Yazdany J, Liew J, Grainger R, Wallace Z, Jayatilleke A. The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey. 2022. PMID: 35392427


  16. Ugarte-Gil MF, Alarcón GS, Izadi Z, Duarte-García A, Reátegui-Sokolova C, Clarke AE, Wise L, Pons-Estel GJ, Santos MJ, Bernatsky S, Ribeiro SLE, Al Emadi S, Sparks JA, Hsu TY, Patel NJ, Gilbert EL, Valenzuela-Almada MO, Jönsen A, Landolfi G, Fredi M, Goulenok T, Devaux M, Mariette X, Queyrel V, Romão VC, Sequeira G, Hasseli R, Hoyer B, Voll RE, Specker C, Baez R, Castro-Coello V, Maldonado Ficco H, Reis Neto ET, Ferreira GAA, Monticielo OAA, Sirotich E, Liew J, Hausmann J, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Jacobsohn L, Taylor T, Ja C, Strangfeld A, Mateus EF, Hyrich KL, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schäfer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. 2022. PMID: 35172961


  17. Humbert-Droz M, Izadi Z, Schmajuk G, Gianfrancesco M, Baker MC, Yazdany J, Tamang S. Development of a natural language processing system for extracting rheumatoid arthritis outcomes from clinical notes using the national RISE registry. 2022. PMID: 35157365


  18. Hausmann JS, Kennedy K, Surangiwala S, Larche MJ, Sinha R, Durrant K, Foster G, Levine M, Thabane L, Costello W, Robinson PC, Liew JW, Yazdany J, Sirotich E. Early impacts of the COVID-19 pandemic on children with pediatric rheumatic diseases. 2022. PMID: 35156622


  19. Putman M, Kennedy K, Sirotich E, Liew JW, Sattui SE, Moni TT, Akpabio AA, Alpizar-Rodriguez D, Angevare S, Beesley RP, Berenbaum F, Bulina I, Chock YPE, Conway R, Duarte-García A, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard R, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AHJ, Liew DFL, Lo C, Mateus EF, Miller B, Mingolla S, Nudel M, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Zamora-Tehozol EA, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché MJ, Levine M, Foster G, Thabane L, Hausmann JS, Sparks JA, Simard JF. COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. 2022. PMID: 35156060


  20. Hammam N, Evans M, Morgan E, Reimold A, Anastasiou C, Kay JL, Yazdany J, Schmajuk G. Treatment of Sarcoidosis in U.S. Rheumatology Practices: Data from ACR's Rheumatology Informatics System for Effectiveness (RISE) Registry. 2020. PMID: 33105057


  21. Schmajuk G, Li J, Evans M, Anastasiou C, Kay JL, Yazdany J. Quality of care for patients with SLE: data from the American College of Rheumatology's RISE registry. 2020. PMID: 32937019


  22. Izadi Z, Schmajuk G, Gianfrancesco M, Subash M, Evans M, Trupin L, Yazdany J. Rheumatology Informatics System for Effectiveness (RISE) Practices See Significant Gains in Rheumatoid Arthritis Quality Measures. 2020. PMID: 32937026


  23. Ackerman SL, Gourley G, Le G, Williams P, Yazdany J, Sarkar U. Improving Patient Safety in Public Hospitals: Developing Standard Measures to Track Medical Errors and Process Breakdowns. 2018. PMID: 29543667


  24. Yeoh SA, Young K, Putman M, Sattui S, Conway R, Graef E, Kilian A, Konig M, Sparks J, Ugarte-Gil M, Upton L, Berenbaum F, Bhana S, Costello W, Hausmann J, Machado P, Robinson P, Sirotich E, Sufka P, Yazdany J, Liew J, Grainger R, Wallace Z, Jayatilleke A, Global Rheumatology Alliance. Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees. 2021. PMID: 34791821


  25. Curtis JR, Zhou X, Rubin DT, Reinisch W, Yazdany J, Robinson PC, Chen Y, Benda B, Madsen A, Geier J. Characteristics, Comorbidities, and Outcomes of SARS-CoV-2 Infection in Patients with Autoimmune Conditions Treated with Systemic Therapies: a Population-based Study. 2021. PMID: 34782447


  26. Sciascia S, Roccatello D, Radin M, Parodis I, Yazdany J, Pons-Estel G, Mosca M. Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. 2021. PMID: 34764455


  27. Sattui SE, Conway R, Putman MS, Seet AM, Gianfrancesco MA, Beins K, Hill C, Liew D, Mackie SL, Mehta P, Neill L, Gomez G, Salinas MIH, Maldonado FN, Mariz HA, de Sousa Studart SA, Araujo NC, Knight A, Rozza D, Quartuccio L, Samson M, Bally S, Maria AT, Chazerain P, Hasseli R, Müller-Ladner U, Hoyer BF, Voll R, Torres RP, Luis M, Ribeirio SLE, Al-Emadi S, Sparks JA, Hsu TY, D'Silva KM, Patel NJ, Wise L, Gilbert E, Almada MV, Duarte-García A, Ugarte-Gil M, Jacobsohn L, Izadi Z, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Sirotich E, Hausmann JS, Sufka P, Bhana S, Liew JW, Grainger R, Machado PM, Wallace ZS, Yazdany J, Robinson PC, Global Rheumatology Alliance. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. 2021. PMID: 34778843


  28. Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD, Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect), Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect). Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. 2021. PMID: 34661663


  29. Bermas BL, Gianfrancesco M, Tanner HL, Seet AM, Aguiar MC, Al Adhoubi NK, Emadi SA, Cunha BM, Flood R, Kusevich DA, McCarthy EM, Patel NJ, Ruderman E, Sattui SE, Sciascia S, Siddique F, Valenzuela-Almada MO, Wise LM, Worthing AB, Zell J, Bhana S, Costello W, Duarte-Garcia A, Grainger R, Gossec L, Hausmann JS, Hyrich K, Lawson-Tovey S, Liew JW, Sirotich E, Sparks J, Sufka P, Wallace Z, Machado PM, Strangfeld A, Clowse MEB, Yazdany J, Robinson PC. COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance. 2021. PMID: 34470798


  30. Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. 2021. PMID: 34493645


  31. Anastasiou C, Trupin L, Glidden DV, Li J, Gianfrancesco M, Shiboski S, Schmajuk G, Yazdany J. Mortality among Hospitalized Individuals with Systemic Lupus Erythematosus in the United States between 2006 and 2016. 2020. PMID: 32558160


  32. Schmajuk G, Montgomery AD, Leonard S, Li J, Gianfrancesco M, Seet A, Izadi Z, Yazdany J, Keyhani S. Factors Associated With Hospitalization and Death After COVID-19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data. 2021. PMID: 34423917


  33. Li J, Ringold S, Curtis JR, Michaud K, Johansson T, Yun H, Yazdany J, Schmajuk G. Effects of the SARS-CoV-2 global pandemic on U.S. rheumatology outpatient care delivery and use of telemedicine: an analysis of data from the RISE registry. 2021. PMID: 34338816


  34. Izadi Z, Li J, Evans M, Hammam N, Katz P, Ogdie A, Suter LG, Yazdany J, Schmajuk G. Socioeconomic Disparities in Functional Status in a National Sample of Patients With Rheumatoid Arthritis. 2021. PMID: 34347058


  35. Hausmann JS, Kennedy K, Simard JF, Liew JW, Sparks JA, Moni TT, Harrison C, Larché MJ, Levine M, Sattui SE, Semalulu T, Foster G, Surangiwala S, Thabane L, Beesley RP, Durrant KL, Mateus EF, Mingolla S, Nudel M, Palmerlee CA, Richards DP, Liew DFL, Hill CL, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Sirotich E, COVID-19 Global Rheumatology Alliance. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. 2021. PMID: 34316727


  36. Subash M, Liu LH, DeQuattro K, Choden S, Jacobsohn L, Katz P, Bajaj P, Barton JL, Bartels C, Bermas B, Danila MI, Downey C, Ferguson S, Reiter K, Wahl E, Weinstein E, Zell J, Schmajuk G, Yazdany J. The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient-Reported Outcome Collection and Patient-Centered Communication in Adult Rheumatology. 2021. PMID: 34288595


  37. Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H, NIH COVID-19 Treatment Guidelines Panel , Aberg JA, Adimora AA, Baker J, Kreuziger LB, Bedimo R, Belperio PS, Cantrill SV, Coopersmith CM, Davis SL, Dzierba AL, Gallagher JJ, Glidden DV, Grund B, Hardy EJ, Hinkson C, Hughes BL, Johnson S, Keller MJ, Kim AY, Lennox JL, Levy MM, Li JZ, Martin GS, Naggie S, Pavia AT, Seam N, Simpson SQ, Swindells S, Tien P, Waghmare AA, Wilson KC, Yazdany J, Zachariah P, Campbell DM, Harrison C, Burgess T, Francis J, Sheikh V, Uyeki TM, Walker R, Brooks JT, Ortiz LB, Davey RT, Doepel LK, Eisinger RW, Han A, Higgs ES, Nason MC, Crew P, Lerner AM, Lund C, Worthington C. Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19. 2021. PMID: 34125574


  38. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Yazdany J, COVID-19 Global Rheumatology Alliance. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. 2021. PMID: 34049860


  39. Hyrich KL, Schäfer M, Strangfeld A, Carmona L, Gossec L, Mateus EF, Lawson-Tovey S, Gianfrancesco M, Robinson PC, Yazdany J, Machado PM. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Rosenbaum et al. 2021. PMID: 33985941


  40. Andreoletti G, Lanata CM, Trupin L, Paranjpe I, Jain TS, Nititham J, Taylor KE, Combes AJ, Maliskova L, Ye CJ, Katz P, Dall'Era M, Yazdany J, Criswell LA, Sirota M. Transcriptomic analysis of immune cells in a multi-ethnic cohort of systemic lupus erythematosus patients identifies ethnicity- and disease-specific expression signatures. 2021. PMID: 33883687


  41. Schäfer M, Strangfeld A, Hyrich KL, Carmona L, Gianfrancesco M, Lawson-Tovey S, Mateus EF, Gossec L, Robinson PC, Yazdany J, Machado PM. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry'' by Mulhearn et al. 2021. PMID: 33648957


  42. Conway R, Konig MF, Graef ER, Webb K, Yazdany J, Kim AHJ. Inflammatory arthritis in patients with COVID-19. 2021. PMID: 33626415


  43. Gianfrancesco MA, Dall'Era M, Murphy LB, Helmick CG, Li J, Rush S, Trupin L, Yazdany J. Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons - California, 2007-2017. 2021. PMID: 33600382


  44. Machado PM, Schäfer M, Strangfeld A, Gossec L, Gianfrancesco M, Lawson-Tovey S, Mateus EF, Carmona L, Hyrich KL, Robinson PC, Yazdany J. Response to: 'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry' by Arnaud and Devilliers. 2021. PMID: 33602795


  45. Taylor T, Yazdany J, Gianfrancesco MA. The racial/ethnic and sociocultural aspects of the pandemic in rheumatology. 2021. PMID: 33648855


  46. Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Hsu TY, D'Silva KM, Serling-Boyd N, Wallwork R, Todd DJ, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Machado PM, Robinson PC, Yazdany J, COVID-19 Global Rheumatology Alliance. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry. 2021. PMID: 33146001


  47. Calabrese LH, Winthrop K, Strand V, Yazdany J, Walter JE. Type I interferon, anti-interferon antibodies, and COVID-19. 2021. PMID: 33655222


  48. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM, COVID-19 Global Rheumatology Alliance. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. 2021. PMID: 33504483


  49. Liew JW, Bhana S, Costello W, Hausmann JS, Machado PM, Robinson PC, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Grainger R. The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice. 2020. PMID: 32789449


  50. Feldman CH, Speyer C, Ashby R, Bermas B, Bhattacharyya S, Chakravarty E, Everett B, Ferucci E, Hersh AO, Marty FM, Merola JF, Ramsey-Goldman R, Rovin BH, Son MB, Tarter L, Waikar S, Yazdany J, Weissman JS, Costenbader KH. Development of a Set of Lupus-Specific Ambulatory Care Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. 2019. PMID: 31628721


  51. Katz P, Dall'Era M, Trupin L, Rush S, Murphy LB, Lanata C, Criswell LA, Yazdany J. The impact of limited health literacy on patient-reported outcomes in systemic lupus erythematosus. 2020. PMID: 32741118


  52. Dietz B, Katz P, Dall'Era M, Murphy LB, Lanata C, Trupin L, Criswell LA, Yazdany J. Major Depression and Adverse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Results from the California Lupus Epidemiology Study. 2020. PMID: 32741124


  53. Pau AK, Aberg J, Baker J, Belperio PS, Coopersmith C, Crew P, Glidden DV, Grund B, Gulick RM, Harrison C, Kim A, Lane HC, Masur H, Sheikh V, Singh K, Yazdany J, Tebas P. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. 2020. PMID: 32976026


  54. Yazdany J. COVID-19 in Rheumatic Diseases: A Research Agenda. 2020. PMID: 32705748


  55. Yazdany J, Pooley N, Langham J, Nicholson L, Langham S, Embleton N, Wang X, Desta B, Barut V, Hammond E. Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis. 2020. PMID: 32900883


  56. Hausmann JS, Sufka P, Bhana S, Liew JW, Machado PM, Wallace ZS, Costello W, Robinson PC, Yazdany J, Grainger R, Sirotich E. Conducting research in a pandemic: The power of social media. 2020. PMID: 32716838


  57. Gianfrancesco MA, McCulloch CE, Trupin L, Graf J, Schmajuk G, Yazdany J. Reweighting to address nonparticipation and missing data bias in a longitudinal electronic health record study. 2020. PMID: 32807591


  58. Gianfrancesco M, Hyrich KL, Yazdany J, Machado PM, Robinson PC. Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al. 2020. PMID: 32606045


  59. Wallace ZS, Bhana S, Hausmann JS, Robinson PC, Sufka P, Sirotich E, Yazdany J, Grainger R. The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance. 2020. PMID: 32374851


  60. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. 2020. PMID: 32471903


  61. Clarke AE, Yazdany J, Kabadi SM, Durden E, Winer I, Griffing K, Costenbader KH. The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States. 2020. PMID: 32531505


  62. Kulhawy-Wibe SC, Zell J, Michaud K, Yazdany J, Davis AM, Ehrlich-Jones L, Thorne JC, Everix D, Cappelli LC, Suter LG, Limanni A, Barber CEH. A Systematic Review and Appraisal of the Cross-Cultural Validity of Functional Status Assessments Measures in Rheumatoid Arthritis. 2019. PMID: 30980507


  63. Aggarwal I, Li J, Trupin L, Gaynon L, Katz PP, Lanata C, Criswell L, Murphy LB, Dall'Era M, Yazdany J. Quality of Care for the Screening, Diagnosis, and Management of Lupus Nephritis Across Multiple Healthcare Settings. 2019. PMID: 31058460


  64. Konig MF, Kim AH, Scheetz MH, Graef ER, Liew JW, Simard J, Machado PM, Gianfrancesco M, Yazdany J, Langguth D, Robinson PC. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19. 2020. PMID: 32381561


  65. Maningding E, Dall'Era M, Trupin L, Murphy LB, Yazdany J. Racial/Ethnic Differences in Prevalence of and Time to Onset of SLE Manifestations: The California Lupus Surveillance Project (CLSP). Volume 72 of Issue 5. 2019. PMID: 31115180


  66. Gianfrancesco MA, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, Sufka P, Grainger R, Wallace Z, Bhana S, Sirotich E, Liew J, Hausmann JS, Costello W, Robinson P, Machado PM, Yazdany J. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. 2020. PMID: 32309814


  67. Norgeot B, Muenzen K, Peterson TA, Fan X, Glicksberg BS, Schenk G, Rutenberg E, Oskotsky B, Sirota M, Yazdany J, Schmajuk G, Ludwig D, Goldstein T, Butte AJ. Protected Health Information filter (Philter): accurately and securely de-identifying free-text clinical notes. 2020. PMID: 32337372


  68. Liu LH, Garrett SB, Li J, Ragouzeos D, Berrean B, Dohan D, Katz PP, Barton JL, Yazdany J, Schmajuk G. Patient and clinician perspectives on a patient-facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis. 2020. PMID: 32270591


  69. DeQuattro K, Trupin L, Li J, Katz PP, Murphy LB, Yelin EH, Rush S, Lanata C, Criswell LA, Dall'Era M, Yazdany J. Relationships Between Adverse Childhood Experiences and Health Status in Systemic Lupus Erythematosus. Volume 72 of Issue 4. 2020. PMID: 31069933


  70. Schmajuk G, Li J, Evans M, Anastasiou C, Izadi Z, Kay JL, Hammam N, Yazdany J. RISE registry reveals potential gaps in medication safety for new users of biologics and targeted synthetic DMARDs. 2020. PMID: 32234243


  71. Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, Criswell LA. Author Correction: A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. Volume 11 of Issue 1. 2020. PMID: 32109229


  72. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Volume 72 of Issue 4. 2020. PMID: 32090466


  73. Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, Marder W, Guyatt G, Branch DW, Buyon J, Christopher-Stine L, Crow-Hercher R, Cush J, Druzin M, Kavanaugh A, Laskin CA, Plante L, Salmon J, Simard J, Somers EC, Steen V, Tedeschi SK, Vinet E, White CW, Yazdany J, Barbhaiya M, Bettendorf B, Eudy A, Jayatilleke A, Shah AA, Sullivan N, Tarter LL, Birru Talabi M, Turgunbaev M, Turner A, D'Anci KE. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Volume 72 of Issue 4. 2020. PMID: 32090480


  74. Aguirre A, Trupin L, Margaretten M, Goglin S, Noh JH, Yazdany J. Using process improvement and systems redesign to improve rheumatology care quality in a safety net clinic. 2020. PMID: 32062597


  75. Yazdany J, Hannan MT. Reimagining Rheumatology: Big Data and the Future of Clinical Practice and Research. Volume 72 of Issue 2. 2020. PMID: 31651101


  76. Gandrup J, Li J, Izadi Z, Gianfrancesco M, Ellingsen T, Yazdany J, Schmajuk G. Three Quality Improvement Initiatives and Performance of Rheumatoid Arthritis Disease Activity Measures in Electronic Health Records: Results From an Interrupted Time Series Study. Volume 72 of Issue 2. 2020. PMID: 30740931


  77. Barber CEH, Zell J, Yazdany J, Davis AM, Cappelli L, Ehrlich-Jones L, Everix D, Thorne JC, Bohm V, Suter L, Limanni A, Michaud K. 2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis. Volume 71 of Issue 12. 2019. PMID: 31709771


  78. Katz P, Yazdany J, Trupin L, Rush S, Helmick CG, Murphy LB, Lanata C, Criswell LA, Dall'Era M. Psychometric Evaluation of the National Institutes of Health Patient-Reported Outcomes Measurement Information System in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort. Volume 71 of Issue 12. 2019. PMID: 30354017


  79. Strait A, Castillo F, Choden S, Li J, Whitaker E, Falasinnu T, Schmajuk G, Yazdany J. Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review. Volume 2 of Issue 11. 2019. PMID: 31722023


  80. Lanata CM, Paranjpe I, Nititham J, Taylor KE, Gianfrancesco M, Paranjpe M, Andrews S, Chung SA, Rhead B, Barcellos LF, Trupin L, Katz P, Dall'Era M, Yazdany J, Sirota M, Criswell LA. A phenotypic and genomics approach in a multi-ethnic cohort to subtype systemic lupus erythematosus. Volume 10 of Issue 1. 2019. PMID: 31467281


  81. Izadi Z, Katz PP, Schmajuk G, Gandrup J, Li J, Gianfrancesco M, Yazdany J. Effects of Language, Insurance, and Race/Ethnicity on Measurement Properties of the PROMIS Physical Function Short Form 10a in Rheumatoid Arthritis. Volume 71 of Issue 7. 2019. PMID: 30099861


  82. Heshin-Bekenstein M, Trupin L, Yelin E, von Scheven E, Yazdany J, Lawson EF. Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus. Volume 49 of Issue 2. 2019. PMID: 31235075


  83. Singh JA, Fraenkel L, Green C, Alarcón GS, Barton JL, Saag KG, Hanrahan LM, Raymond SC, Kimberly RP, Leong AL, Reyes E, Street RL, Suarez-Almazor ME, Eakin GS, Marrow L, Morgan CJ, Caro B, Sloan JA, Jandali B, Garcia SR, Grossman J, Winthrop KL, Trupin L, Dall'Era M, Meara A, Rizvi T, Chatham WW, Yazdany J. Individualized decision aid for diverse women with lupus nephritis (IDEA-WON): A randomized controlled trial. Volume 16 of Issue 5. 2019. PMID: 31067237


  84. Gandrup J, Yazdany J. Using Health Information Technology to Support Use of Patient-Reported Outcomes in Rheumatology. Volume 45 of Issue 2. 2019. PMID: 30952397


  85. Gianfrancesco MA, Trupin L, McCulloch CE, Shiboski S, Schmajuk G, Yazdany J. Differences in Longitudinal Disease Activity Between Research Cohort and Noncohort Participants with Rheumatoid Arthritis Using Electronic Health Record Data. Volume 1 of Issue 2. 2019. PMID: 31777787


  86. Yelin E, Trupin L, Yazdany J. Reply. Volume 71 of Issue 5. 2019. PMID: 29609222


  87. Ying D, Gianfrancesco MA, Trupin L, Yazdany J, Greidinger EL, Schmajuk G. Increased Risk of Ischemic Stroke in Systemic Sclerosis: A National Cohort Study of US Veterans. Volume 47 of Issue 1. 2019. PMID: 30877213


  88. Norgeot B, Glicksberg BS, Trupin L, Lituiev D, Gianfrancesco M, Oskotsky B, Schmajuk G, Yazdany J, Butte AJ. Assessment of a Deep Learning Model Based on Electronic Health Record Data to Forecast Clinical Outcomes in Patients With Rheumatoid Arthritis. Volume 2 of Issue 3. 2019. PMID: 30874779


  89. Liu LH, Choden S, Yazdany J. Quality improvement initiatives in rheumatology: an integrative review of the last 5 years. Volume 31 of Issue 2. 2019. PMID: 30608250


  90. Patterson S, Schmajuk G, Evans M, Aggarwal I, Izadi Z, Gianfrancesco M, Yazdany J. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. Volume 45 of Issue 5. 2019. PMID: 30686706


  91. Murray SG, Avati A, Schmajuk G, Yazdany J. Automated and flexible identification of complex disease: building a model for systemic lupus erythematosus using noisy labeling. Volume 26 of Issue 1. 2019. PMID: 30476175


  92. Patterson SL, Schmajuk G, Jafri K, Yazdany J, Katz P. Obesity is Independently Associated With Worse Patient-Reported Outcomes in Women with Systemic Lupus Erythematosus. Volume 71 of Issue 1. 2019. PMID: 29740985


  93. Sciascia S, Yazdany J, Dall'Era M, Fenoglio R, Radin M, Aggarwal I, Cuadrado MJ, Schreiber K, Barreca A, Papotti M, Roccatello D. Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: a multicentre cohort study. Volume 78 of Issue 7. 2018. PMID: 30552172


  94. Gianfrancesco MA, Trupin L, Shiboski S, van der Laan M, Graf J, Imboden J, Yazdany J, Schmajuk G. Smoking Is Associated with Higher Disease Activity in Rheumatoid Arthritis: A Longitudinal Study Controlling for Time-varying Covariates. Volume 46 of Issue 4. 2018. PMID: 30504507


  95. Yazdany J, Caplan L, Fitzgerald J, Schmajuk G. Editorial: The Evolving Art and Science of American College of Rheumatology Guidelines. Volume 71 of Issue 1. 2018. PMID: 30499229


  96. Arora S, Nika A, Trupin L, Abraham H, Block J, Sequeira W, Yazdany J, Jolly M. Does Systemic Lupus Erythematosus Care Provided in a Lupus Clinic Result in Higher Quality of Care Than That Provided in a General Rheumatology Clinic? Volume 70 of Issue 12. 2018. PMID: 29609210


  97. Schmajuk G, Jafri K, Evans M, Shiboski S, Gianfrancesco M, Izadi Z, Patterson SL, Aggarwal I, Sarkar U, Dudley RA, Yazdany J. Pneumocystis jirovecii pneumonia (PJP) prophylaxis patterns among patients with rheumatic diseases receiving high-risk immunosuppressant drugs. 2018. PMID: 30449650


  98. Khoong EC, Cherian R, Rivadeneira NA, Gourley G, Yazdany J, Amarnath A, Schillinger D, Sarkar U. Accurate Measurement In California's Safety-Net Health Systems Has Gaps And Barriers. 2018. PMID: 30395496


  99. Schmajuk G, Yazdany J. Further Lessons in Pneumocystis Pneumonia Prophylaxis. Volume 178 of Issue 11. 2018. PMID: 30398556


  100. Gianfrancesco MA, Tamang S, Yazdany J, Schmajuk G. Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data. Volume 178 of Issue 11. 2018. PMID: 30128552


  101. Ragouzeos D, Gandrup J, Berrean B, Li J, Murphy M, Trupin L, Yazdany J, Schmajuk G. "Am I OK?" using human centered design to empower rheumatoid arthritis patients through patient reported outcomes. Volume 102 of Issue 3. 2018. PMID: 30446358


  102. Yazdany J, Dudley RA, Lin GA, Chen R, Tseng CW. Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D. Volume 320 of Issue 9. 2018. PMID: 30193264


  103. Izadi Z, Gandrup J, Katz PP, Yazdany J. Patient-reported outcome measures for use in clinical trials of SLE: a review. Volume 5 of Issue 1. 2018. PMID: 30167315


  104. Li J, Yazdany J, Trupin L, Izadi Z, Gianfrancesco M, Goglin S, Schmajuk G. Capturing a Patient-Reported Measure of Physical Function Through an Online Electronic Health Record Patient Portal in an Ambulatory Clinic: Implementation Study. Volume 6 of Issue 2. 2018. PMID: 29743158


  105. Yelin E, Yazdany J, Trupin L. Relationship Between Poverty and Mortality in Systemic Lupus Erythematosus. Volume 70 of Issue 7. 2018. PMID: 28973834


  106. Heshin-Bekenstein M, Perl L, Hersh AO, von Scheven E, Yelin E, Trupin L, Yazdany J, Lawson EF. Final adult height of patients with childhood-onset systemic lupus erythematosus: a cross sectional analysis. Volume 16 of Issue 1. 2018. PMID: 29688869


  107. Feldman CH, Broder A, Guan H, Yazdany J, Costenbader KH. Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis. Volume 70 of Issue 3. 2018. PMID: 29193893


  108. Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M, Dudley RA, Yazdany J. Correction to: Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Volume 38 of Issue 2. 2018. PMID: 29273937


  109. Jafri K, Ogdie A, Qasim A, Patterson SL, Gianfrancesco M, Izadi Z, Katz P, Yazdany J, Schmajuk G. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis. Volume 37 of Issue 2. 2017. PMID: 28993952


  110. Schmajuk G, Yazdany J. Leveraging the electronic health record to improve quality and safety in rheumatology. Volume 37 of Issue 10. 2017. PMID: 28852846


  111. Gianfrancesco MA, Schmajuk G, Haserodt S, Trupin L, Izadi Z, Jafri K, Shiboski S, Sirota M, Yazdany J. Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety. Volume 37 of Issue 10. 2017. PMID: 28748425


  112. Yelin E, Yazdany J, Trupin L. Relationship Between Process of Care and a Subsequent Increase in Damage in Systemic Lupus Erythematosus. Volume 69 of Issue 6. 2017. PMID: 27477567


  113. Schmajuk G, Tonner C, Trupin L, Yazdany J. Variations in Radiographic Procedure Use for Medicare Patients With Rheumatoid Arthritis. Volume 69 of Issue 5. 2017. PMID: 27390167


  114. Tseng CW, Yazdany J, Dudley RA, DeJong C, Kazi DS, Chen R, Lin GA. Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease. Volume 177 of Issue 4. 2017. PMID: 28241217


  115. Sciascia S, Radin M, Yazdany J, Tektonidou M, Cecchi I, Roccatello D, Dall'Era M. Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence. Volume 37 of Issue 8. 2017. PMID: 28258475


  116. Tonner C, Schmajuk G, Yazdany J. A new era of quality measurement in rheumatology: electronic clinical quality measures and national registries. Volume 29 of Issue 2. 2017. PMID: 27941392


  117. Katz P, Margaretten M, Schmajuk G, Yazdany J, Yelin E. Reply. Volume 69 of Issue 3. 2017. PMID: 28129462


  118. Schmajuk G, Tonner C, Trupin L, Li J, Sarkar U, Ludwig D, Shiboski S, Sirota M, Dudley RA, Murray S, Yazdany J. Using health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab. Volume 96 of Issue 13. 2017. PMID: 28353614


  119. Wahl E, Gross A, Chernitskiy V, Trupin L, Gensler L, Chaganti K, Michaud K, Katz P, Yazdany J. Validity and Responsiveness of a 10-Item Patient-Reported Measure of Physical Function in a Rheumatoid Arthritis Clinic Population. Volume 69 of Issue 3. 2017. PMID: 27332620


  120. Katz PP, Andrews J, Yazdany J, Schmajuk G, Trupin L, Yelin E. Is frailty a relevant concept in SLE? Volume 4 of Issue 1. 2017. PMID: 28243456


  121. Sciascia S, Radin M, Yazdany J, Levy RA, Roccatello D, Dall'Era M, Cuadrado MJ. Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review. Volume 16 of Issue 3. 2017. PMID: 28147262


  122. Schmajuk G, Tonner C, Miao Y, Yazdany J, Gannon J, Boscardin WJ, Daikh DI, Steinman MA. Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate. Volume 11 of Issue 12. 2016. PMID: 27977768


  123. Qu H, Shewchuk RM, Alarcón G, Fraenkel L, Leong A, Dall'Era M, Yazdany J, Singh JA. Mapping Perceptions of Lupus Medication Decision-Making Facilitators: The Importance of Patient Context. Volume 68 of Issue 12. 2016. PMID: 27059939


  124. Yazdany J, Bansback N, Clowse M, Collier D, Law K, Liao KP, Michaud K, Morgan EM, Oates JC, Orozco C, Reimold A, Simard JF, Myslinski R, Kazi S. Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement. Volume 68 of Issue 12. 2016. PMID: 27696755


  125. Yazdany J, Robbins M, Schmajuk G, Desai S, Lacaille D, Neogi T, Singh JA, Genovese M, Myslinski R, Fisk N, Francisco M, Newman E. Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures. Volume 68 of Issue 11. 2016. PMID: 27564778


  126. Tseng CW, Lin GA, Davis J, Taira DA, Yazdany J, He Q, Chen R, Imamura A, Dudley RA. Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study. Volume 16 of Issue 1. 2016. PMID: 27654857


  127. Suter LG, Barber CE, Herrin J, Leong A, Losina E, Miller A, Newman E, Robbins M, Tory H, Yazdany J. American College of Rheumatology White Paper on Performance Outcome Measures in Rheumatology. Volume 68 of Issue 10. 2016. PMID: 27159835


  128. Yazdany J, Myslinski R, Miller A, Francisco M, Desai S, Schmajuk G, Lacaille D, Barber CE, Orozco C, Bunyard M, Bergman MJ, Passo M, Matteson EL, Olson R, Silverman S, Warren R, Nola K, Robbins M. Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures. Volume 68 of Issue 10. 2016. PMID: 27390129


  129. Bays A, Wahl E, Daikh DI, Yazdany J, Schmajuk G. Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic. Volume 16 of Issue a. 2016. PMID: 27527720


  130. Katz PP, Barton J, Trupin L, Schmajuk G, Yazdany J, Ruiz PJ, Yelin E. Poverty, Depression, or Lost in Translation? Ethnic and Language Variation in Patient-Reported Outcomes in Rheumatoid Arthritis. Volume 68 of Issue 5. 2016. PMID: 26414775


  131. Murray SG, Schmajuk G, Trupin L, Gensler L, Katz PP, Yelin EH, Gansky SA, Yazdany J. National Lupus Hospitalization Trends Reveal Rising Rates of Herpes Zoster and Declines in Pneumocystis Pneumonia. Volume 11 of Issue 1. 2016. PMID: 26731012


  132. Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Role of Sleep Disturbance, Depression, Obesity, and Physical Inactivity in Fatigue in Rheumatoid Arthritis. Volume 68 of Issue 1. 2016. PMID: 25779719


  133. Singh JA, Qu H, Yazdany J, Chatham W, Shewchuk R. Minorities with lupus nephritis and medications: a study of facilitators to medication decision-making. Volume 17. 2015. PMID: 26680561


  134. Feldman CH, Yazdany J, Guan H, Solomon DH, Costenbader KH. Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus. Volume 67 of Issue 12. 2015. PMID: 26097166


  135. Davis LA, Goldstein B, Tran V, Keniston A, Yazdany J, Hirsh J, Storfa A, Zell J. Applying Choosing Wisely: Antinuclear Antibody (ANA) and Sub-Serology Testing in a Safety Net Hospital System. Volume 9. 2015. PMID: 26862352


  136. Sapir T, Rusie E, Greene L, Yazdany J, Robbins ML, Ruderman EM, Carter JD, Patel B, Moreo K. Influence of Continuing Medical Education on Rheumatologists' Performance on National Quality Measures for Rheumatoid Arthritis. Volume 2 of Issue 2. 2015. PMID: 27747535


  137. Scheibe MM, Imboden JB, Schmajuk G, Margaretten M, Graf JD, Chen AH, Yelin EH, Yazdany J. Efficiency Gains for Rheumatology Consultation Using a Novel Electronic Referral System in a Safety-Net Health Setting. Volume 67 of Issue 8. 2015. PMID: 25623810


  138. Andrews JS, Trupin L, Schmajuk G, Barton J, Margaretten M, Yazdany J, Yelin EH, Katz PP. Muscle Strength and Changes in Physical Function in Women With Systemic Lupus Erythematosus. Volume 67 of Issue 8. 2015. PMID: 25623919


  139. Schmajuk G, Tonner C, Yazdany J. Factors associated with access to rheumatologists for Medicare patients. Volume 45 of Issue 4. 2015. PMID: 26319646


  140. Singh JA, Qu H, Yazdany J, Chatham W, Dall'era M, Shewchuk RM. Barriers to Medication Decision Making in Women with Lupus Nephritis: A Formative Study using Nominal Group Technique. Volume 42 of Issue 9. 2015. PMID: 26178276


  141. Rai SK, Yazdany J, Fortin PR, Aviña-Zubieta JA. Approaches for estimating minimal clinically important differences in systemic lupus erythematosus. Volume 17. 2015. PMID: 26036334


  142. Duseja R, Bardach NS, Lin GA, Yazdany J, Dean ML, Clay TH, Boscardin WJ, Dudley RA. Revisit rates and associated costs after an emergency department encounter: a multistate analysis. Volume 162 of Issue 11. 2015. PMID: 26030633


  143. Yazdany J, Dudley RA, Chen R, Lin GA, Tseng CW. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D. Volume 67 of Issue 6. 2015. PMID: 25900105


  144. Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, Margaretten M, Katz PP, Yelin EH, Yazdany J. A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis. Volume 67 of Issue 5. 2015. PMID: 25331828


  145. Yelin E, Yazdany J, Tonner C, Trupin L, Criswell LA, Katz P, Schmajuk G. Interactions between patients, providers, and health systems and technical quality of care. Volume 67 of Issue 3. 2015. PMID: 25132660


  146. Schmajuk G, Bozic KJ, Yazdany J. Using medicare data to understand health care value--reply. Volume 175 of Issue 3. 2015. PMID: 25730567


  147. Andrews JS, Trupin L, Schmajuk G, Barton J, Margaretten M, Yazdany J, Yelin EH, Katz PP. Muscle strength, muscle mass, and physical disability in women with systemic lupus erythematosus. Volume 67 of Issue 1. 2015. PMID: 25049114


  148. Yazdany J, Tonner C, Schmajuk G, Lin GA, Trivedi AN. Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis. Volume 66 of Issue 10. 2014. PMID: 25244314


  149. Yazdany J, Marafino BJ, Dean ML, Bardach NS, Duseja R, Ward MM, Dudley RA. Thirty-day hospital readmissions in systemic lupus erythematosus: predictors and hospital- and state-level variation. Volume 66 of Issue 10. 2014. PMID: 25110993


  150. Schmajuk G, Bozic KJ, Yazdany J. Using Medicare data to understand low-value health care: the case of intra-articular hyaluronic acid injections. Volume 174 of Issue 10. 2014. PMID: 25156406


  151. Quinzanos I, Davis L, Keniston A, Nash A, Yazdany J, Fransen R, Hirsh JM, Zell J. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. Volume 24 of Issue 2. 2014. PMID: 25267076


  152. Schmajuk G, Miao Y, Yazdany J, Boscardin WJ, Daikh DI, Steinman MA. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Volume 66 of Issue 8. 2014. PMID: 24470205


  153. Katz P, Trupin L, Rush S, Yazdany J. Longitudinal validation of the Brief Index of Lupus Damage. Volume 66 of Issue 7. 2014. PMID: 24376263


  154. Simard JF, Yazdany J. Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE. Volume 1 of Issue 1. 2014. PMID: 25379195


  155. Askanase AD, Yazdany J, Molta CT. Post-marketing experiences with belimumab in the treatment of SLE patients. Volume 40 of Issue 3. 2014. PMID: 25034159


  156. Drenkard C, Yazdany J, Trupin L, Katz PP, Dunlop-Thomas C, Bao G, Lim SS. Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort. Volume 66 of Issue 6. 2014. PMID: 24249662


  157. Lawson EF, Hersh AO, Trupin L, von Scheven E, Okumura MJ, Yazdany J, Yelin EH. Educational and vocational outcomes of adults with childhood- and adult-onset systemic lupus erythematosus: nine years of followup. Volume 66 of Issue 5. 2014. PMID: 24877200


  158. Yazdany J, Feldman CH, Liu J, Ward MM, Fischer MA, Costenbader KH. Quality of care for incident lupus nephritis among Medicaid beneficiaries in the United States. Volume 66 of Issue 4. 2014. PMID: 24124011


  159. Yazdany J, Trupin L, Schmajuk G, Katz PP, Yelin EH. Quality of care in systemic lupus erythematosus: the association between process and outcome measures in the Lupus Outcomes Study. Volume 23 of Issue 8. 2014. PMID: 24614054


  160. Lawson EF, Trupin L, Hersh AO, Scheven Ev, Yelin EH, Yazdany J. A168: systemic lupus erythematosus in-hospital mortality risk across ages: a national estimate. 2014. PMID: 24677924


  161. Desai SP, Liu CC, Tory H, Norton T, Frits M, Lillegraven S, Weinblatt M, Coblyn J, Yazdany J, Shadick N, Solomon DH. Rheumatoid arthritis quality measures and radiographic progression. Volume 44 of Issue 1. 2014. PMID: 24560878


  162. Schmajuk G, Solomon DH, Yazdany J. Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review. Volume 65 of Issue 12. 2013. PMID: 23926092


  163. Bardach NS, Vittinghoff E, Asteria-Peñaloza R, Edwards JD, Yazdany J, Lee HC, Boscardin WJ, Cabana MD, Dudley RA. Measuring hospital quality using pediatric readmission and revisit rates. Volume 132 of Issue 3. 2013. PMID: 23979094


  164. Grossman JM, Hahn BH, McMahon MA, Fitzgerald JD, Merrill JT, Yazdany J, Wallace DJ, Ramsey-Goldman R. Reply: To PMID 22556106. Volume 65 of Issue 8. 2013. PMID: 23495047


  165. Tarter L, Yazdany J, Moyers B, Barnett C, Dhaliwal G. Clinical problem-solving. The heart of the matter. Volume 368 of Issue 10. 2013. PMID: 23465105


  166. Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, Barton J, Carlson A, Margaretten M, Zell J, Gensler LS, Kelly V, Saag K, King C. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Volume 65 of Issue 3. 2013. PMID: 23436818


  167. Richman NC, Yazdany J, Graf J, Chernitskiy V, Imboden JB. Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Volume 92 of Issue 2. 2013. PMID: 23429352


  168. Katz PP, Yazdany J, Trupin L, Schmajuk G, Margaretten M, Barton J, Criswell LA, Yelin EH. Sex differences in assessment of obesity in rheumatoid arthritis. Volume 65 of Issue 1. 2013. PMID: 22833513


  169. Turchetti G, Yazdany J, Palla I, Yelin E, Mosca M. Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to consider. Volume 30 of Issue 4 Suppl 73. 2012. PMID: 23072767


  170. Murray SG, Yazdany J, Kaiser R, Criswell LA, Trupin L, Yelin EH, Katz PP, Julian LJ. Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus. Volume 64 of Issue 9. 2012. PMID: 22549897


  171. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Volume 64 of Issue 6. 2012. PMID: 22556106


  172. Yazdany J, Trupin L, Tonner C, Dudley RA, Zell J, Panopalis P, Schmajuk G, Julian L, Katz P, Criswell LA, Yelin E. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. Volume 27 of Issue 10. 2012. PMID: 22588825


  173. Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Volume 64 of Issue 5. 2012. PMID: 22473918


  174. Katz P, Julian L, Tonner MC, Yazdany J, Trupin L, Yelin E, Criswell LA. Physical activity, obesity, and cognitive impairment among women with systemic lupus erythematosus. Volume 64 of Issue 4. 2012. PMID: 22337564


  175. Julian LJ, Yazdany J, Trupin L, Criswell LA, Yelin E, Katz PP. Validity of brief screening tools for cognitive impairment in rheumatoid arthritis and systemic lupus erythematosus. Volume 64 of Issue 3. 2012. PMID: 22162414


  176. Yelin E, Tonner C, Trupin L, Gansky SA, Julian L, Katz P, Yazdany J, Kaiser R, Criswell LA. Longitudinal study of the impact of incident organ manifestations and increased disease activity on work loss among persons with systemic lupus erythematosus. Volume 64 of Issue 2. 2012. PMID: 22006458


  177. Desai SP, Yazdany J. Quality measurement and improvement in rheumatology: rheumatoid arthritis as a case study. Volume 63 of Issue 12. 2011. PMID: 22127687


  178. Barton JL, Pincus L, Yazdany J, Richman N, McCalmont TH, Gensler L, Dall'era M, Fye KH. Association of Sweet's Syndrome and Systemic Lupus Erythematosus. Volume 2011. 2011. PMID: 22937442


  179. Katz P, Yazdany J, Julian L, Trupin L, Margaretten M, Yelin E, Criswell LA. Impact of obesity on functioning among women with systemic lupus erythematosus. Volume 63 of Issue 10. 2011. PMID: 21702085


  180. Yazdany J, Trupin L, Gansky SA, Dall'era M, Yelin EH, Criswell LA, Katz PP. Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus. Volume 63 of Issue 8. 2011. PMID: 21584946


  181. Julian LJ, Gregorich SE, Tonner C, Yazdany J, Trupin L, Criswell LA, Yelin E, Katz PP. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Volume 63 of Issue 6. 2011. PMID: 21312347


  182. Julian LJ, Tonner C, Yelin E, Yazdany J, Trupin L, Criswell LA, Katz PP. Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Volume 63 of Issue 4. 2011. PMID: 21452266


  183. Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, Yazdany J. Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans. Volume 305 of Issue 5. 2011. PMID: 21285425


  184. Katz P, Gregorich S, Yazdany J, Trupin L, Julian L, Yelin E, Criswell LA. Obesity and its measurement in a community-based sample of women with systemic lupus erythematosus. Volume 63 of Issue 2. 2011. PMID: 20824801


  185. Saag KG, Yazdany J, Alexander C, Caplan L, Coblyn J, Desai SP, Harrington T, Liu J, McNiff K, Newman E, Olson R. Defining quality of care in rheumatology: the American College of Rheumatology white paper on quality measurement. Volume 63 of Issue 1. 2011. PMID: 20945349


  186. Gillis JZ, Panopalis P, Schmajuk G, Ramsey-Goldman R, Yazdany J. Systematic review of the literature informing the systemic lupus erythematosus indicators project: reproductive health care quality indicators. Volume 63 of Issue 1. 2011. PMID: 20734353


  187. Yazdany J, Trupin L, Kaiser R, Schmajuk G, Gillis JZ, Chakravarty E, Schwarz EB. Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Volume 63 of Issue 3. 2010. PMID: 21080446


  188. Schmajuk G, Yazdany J. Drug monitoring in systemic lupus erythematosus: a systematic review. Volume 40 of Issue 6. 2010. PMID: 21030066


  189. Hersh AO, Trupin L, Yazdany J, Panopalis P, Julian L, Katz P, Criswell LA, Yelin E. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Volume 62 of Issue 8. 2010. PMID: 20235215


  190. Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Volume 62 of Issue 7. 2010. PMID: 20589692


  191. Tonner C, Trupin L, Yazdany J, Criswell L, Katz P, Yelin E. Role of community and individual characteristics in physician visits for persons with systemic lupus erythematosus. Volume 62 of Issue 6. 2010. PMID: 20535800


  192. Yazdany J, Tonner C, Trupin L, Panopalis P, Gillis JZ, Hersh AO, Julian LJ, Katz PP, Criswell LA, Yelin EH. Provision of preventive health care in systemic lupus erythematosus: data from a large observational cohort study. Volume 12 of Issue 3. 2010. PMID: 20462444


  193. Yazdany J, Calabrese L. Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines? Volume 62 of Issue 5. 2010. PMID: 20191573


  194. Demas KL, Keenan BT, Solomon DH, Yazdany J, Costenbader KH. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Volume 40 of Issue 3. 2010. PMID: 20378155


  195. Panopalis P, Gillis JZ, Yazdany J, Trupin L, Hersh A, Julian L, Criswell LA, Katz P, Yelin E. Frequent use of the emergency department among persons with systemic lupus erythematosus. Volume 62 of Issue 3. 2010. PMID: 20391487


  196. Schmajuk G, Yazdany J, Trupin L, Yelin E. Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus. Volume 62 of Issue 3. 2010. PMID: 20391485


  197. Yazdany J, Yelin E. Health-related quality of life and employment among persons with systemic lupus erythematosus. Volume 36 of Issue 1. 2010. PMID: 20202589


  198. Panopalis P, Yazdany J. Bone health in systemic lupus erythematosus. Volume 11 of Issue 3. 2009. PMID: 19604461


  199. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, Yelin E. A quality indicator set for systemic lupus erythematosus. Volume 61 of Issue 3. 2009. PMID: 19248127


  200. Julian LJ, Yelin E, Yazdany J, Panopalis P, Trupin L, Criswell LA, Katz P. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Volume 61 of Issue 2. 2009. PMID: 19177526


  201. Yelin E, Tonner C, Trupin L, Panopalis P, Yazdany J, Julian L, Katz P, Criswell LA. Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample. Volume 61 of Issue 2. 2009. PMID: 19177546


  202. Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, Katz P, Criswell LA, Yelin E. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Volume 61 of Issue 1. 2009. PMID: 19116979


  203. Panopalis P, Yazdany J, Gillis JZ, Julian L, Trupin L, Hersh AO, Criswell LA, Katz P, Yelin E. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Volume 59 of Issue 12. 2008. PMID: 19035422


  204. Yazdany J, Maclean C. Comment on "Quality indicators for psoriatic arthritis". Volume 26 of Issue 5. 2008. PMID: 19032840


  205. Katz P, Morris A, Gregorich S, Yazdany J, Eisner M, Yelin E, Blanc P. Valued life activity disability played a significant role in self-rated health among adults with chronic health conditions. Volume 62 of Issue 2. 2008. PMID: 18722089


  206. Trupin L, Tonner MC, Yazdany J, Julian LJ, Criswell LA, Katz PP, Yelin E. The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. Volume 35 of Issue 9. 2008. PMID: 18634153


  207. Katz P, Morris A, Trupin L, Yazdany J, Yelin E. Disability in valued life activities among individuals with systemic lupus erythematosus. Volume 59 of Issue 4. 2008. PMID: 18383406


  208. Yazdany J, MacLean CH. Quality of care in the rheumatic diseases: current status and future directions. Volume 20 of Issue 2. 2008. PMID: 18349745


  209. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Volume 59 of Issue 1. 2008. PMID: 18163398


  210. Panopalis P, Julian L, Yazdany J, Gillis JZ, Trupin L, Hersh A, Criswell LA, Katz P, Yelin E. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Volume 57 of Issue 8. 2007. PMID: 18050187


  211. Yazdany J, Gillis JZ, Trupin L, Katz P, Panopalis P, Criswell LA, Yelin E. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Volume 57 of Issue 4. 2007. PMID: 17471526


  212. Gillis JZ, Yazdany J, Trupin L, Julian L, Panopalis P, Criswell LA, Katz P, Yelin E. Medicaid and access to care among persons with systemic lupus erythematosus. Volume 57 of Issue 4. 2007. PMID: 17471527


  213. Yelin E, Trupin L, Katz P, Criswell LA, Yazdany J, Gillis J, Panopalis P. Impact of health maintenance organizations and fee-for-service on health care utilization among people with systemic lupus erythematosus. Volume 57 of Issue 3. 2007. PMID: 17394180


  214. Gillis JZ, Dall'era M, Gross A, Yazdany J, Davis J. Six refractory lupus patients treated with rituximab: a case series. Volume 57 of Issue 3. 2007. PMID: 17394185


  215. Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, Panopalis P. Work dynamics among persons with systemic lupus erythematosus. Volume 57 of Issue 1. 2007. PMID: 17266065


  216. Yazdany J, Davis J. The role of CD40 ligand in systemic lupus erythematosus. Volume 13 of Issue 5. 2004. PMID: 15230296


  217. Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Volume 156 of Issue 4. 2000. PMID: 10751359